Is routine electroencephalography (EEG) a useful biomarker for pharmacoresistant epilepsy?

Summary People with seizure disorders who have been treated at the Kork Epilepsy Center over a prolonged time period and who thus provide data concerning the chronic course of epilepsy were investigated in order to address the potential role of electroencephalography (EEG) as a biomarker for pharmac...

Full description

Saved in:
Bibliographic Details
Published in:Epilepsia (Copenhagen) 2013-05, Vol.54 (s2), p.63-66
Main Authors: Steinhoff, Bernhard J., Scholly, Julia, Dentel, Christel, Staack, Anke Maren
Format: Article
Language:English
Subjects:
Adolescent
Adult
Anticonvulsants - therapeutic use
Antiepileptic drugs
Biomarkers
Biomarkers - analysis
Child
Child, Preschool
Drug Resistance - physiology
Electroencephalography
Electroencephalography - methods
Epilepsy
Epilepsy - diagnosis
Epilepsy - drug therapy
Epilepsy - physiopathology
Female
Humans
Idiopathic generalized epilepsies
Infant
Infant, Newborn
Interictal epileptiform discharge
Male
Middle Aged
Prognosis
Retrospective Studies
Young Adult
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Summary People with seizure disorders who have been treated at the Kork Epilepsy Center over a prolonged time period and who thus provide data concerning the chronic course of epilepsy were investigated in order to address the potential role of electroencephalography (EEG) as a biomarker for pharmacoresistant epilepsy. Clinical course and the corresponding findings from their first recorded EEG, their first EEG following appropriate treatment, and their last EEG were compared. Furthermore, we investigated if interictal epileptiform discharges (IEDs) differ in amplitude and morphology if recorded in long‐term seizure‐free patients. The early cessation of IEDs was a relatively good marker for a good prognosis, especially in idiopathic generalized epilepsies. However, persistent IEDs had no major impact on the long‐term prognosis. We found no differences between IEDs in seizure‐free patients or patients with ongoing seizures. Therefore, in our hands, routine EEG was not an appropriate biomarker for the prediction of pharmacoresistant epilepsy. Additional factors such as etiology and pathophysiology also need to be considered.
ISSN:0013-9580
1528-1167
DOI:10.1111/epi.12187